A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Genmab A/S stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 17,675 shares of GMAB stock, worth $374,356. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,675
Previous 19,294 8.39%
Holding current value
$374,356
Previous $484,000 11.16%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$23.84 - $28.48 $38,596 - $46,109
-1,619 Reduced 8.39%
17,675 $430,000
Q2 2024

Aug 12, 2024

SELL
$25.13 - $30.27 $11,760 - $14,166
-468 Reduced 2.37%
19,294 $484,000
Q1 2024

May 09, 2024

BUY
$26.43 - $32.77 $147,294 - $182,627
5,573 Added 39.28%
19,762 $591,000
Q4 2023

Feb 07, 2024

SELL
$27.94 - $35.44 $28,163 - $35,723
-1,008 Reduced 6.63%
14,189 $451,000
Q3 2023

Nov 08, 2023

SELL
$35.27 - $42.24 $63,662 - $76,243
-1,805 Reduced 10.62%
15,197 $535,000
Q2 2023

Jul 28, 2023

BUY
$37.4 - $42.94 $40,691 - $46,718
1,088 Added 6.84%
17,002 $646,000
Q1 2023

May 10, 2023

BUY
$34.88 - $43.22 $11,789 - $14,608
338 Added 2.17%
15,914 $600,000
Q4 2022

Feb 10, 2023

BUY
$33.8 - $47.06 $51,240 - $71,342
1,516 Added 10.78%
15,576 $660,000
Q3 2022

Nov 14, 2022

BUY
$31.52 - $373.61 $159,869 - $1.89 Million
5,072 Added 56.43%
14,060 $452,000
Q2 2022

Aug 09, 2022

BUY
$26.83 - $38.57 $27,339 - $39,302
1,019 Added 12.79%
8,988 $292,000
Q1 2022

May 16, 2022

BUY
$30.95 - $39.68 $79,293 - $101,660
2,562 Added 47.38%
7,969 $288,000
Q4 2021

Feb 23, 2022

BUY
$35.87 - $47.12 $1,650 - $2,167
46 Added 0.86%
5,407 $214,000
Q3 2021

Nov 09, 2021

SELL
$41.55 - $48.72 $61,286 - $71,862
-1,475 Reduced 21.58%
5,361 $234,000
Q1 2021

Apr 28, 2021

SELL
$30.92 - $44.4 $55,934 - $80,319
-1,809 Reduced 20.93%
6,836 $224,000
Q4 2020

Jan 20, 2021

BUY
$33.66 - $40.76 $290,990 - $352,370
8,645 New
8,645 $352,000
Q4 2020

Jan 19, 2021

SELL
$33.66 - $40.76 $286,480 - $346,908
-8,511 Closed
0 $0
Q3 2020

Oct 26, 2020

BUY
$33.07 - $38.68 $60,981 - $71,325
1,844 Added 27.66%
8,511 $312,000
Q2 2020

Jul 27, 2020

BUY
$20.05 - $33.89 $133,673 - $225,944
6,667 New
6,667 $226,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.9B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.